Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Blank, C.U.
(-)
= 2023
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(14)
+
-
Availability
Open access
(14)
+
-
Faculty
Leiden University Medical Center (LUMC)
(4)
+
-
Collection
Scholarly Publications
(10)
+
-
Medicine / Leiden University Medical Centre (LUMC)
(4)
+
-
Topic
immunotherapy
(4)
+
-
melanoma
(3)
+
-
immune checkpoint inhibition
(2)
+
-
survival
(2)
+
-
Author
Blank, C.U.
(14)
+
-
Aarts, M.J.B.
(9)
+
-
Boers-Sonderen, M.J.
(9)
+
-
Kapiteijn, E.
(9)
+
-
Piersma, D.
(9)
+
-
Suijkerbuijk, K.P.M.
(9)
+
-
Vreugdenhil, G.
(9)
+
-
Berkmortel, F.W.P.J. van den
(8)
+
-
Eertwegh, A.J.M. van den
(8)
+
-
Groot, J.W.B. de
(8)
+
-
Hospers, G.A.P.
(8)
+
-
Veldt, A.A.M. van der
(8)
+
-
Wouters, M.W.J.M.
(8)
+
-
Rijn, R.S. van
(7)
+
-
Not, O.J. van
(6)
+
-
Blokx, W.A.M.
(5)
+
-
Haanen, J.B.
(4)
+
-
Haanen, J.B.A.G.
(4)
+
-
Boer, M.A.S.D.
(3)
+
-
Breeschoten, J. van
(2)
+
-
Broeks, A.
(2)
+
-
Burgmans, M.C.
(2)
+
-
Hilarius, D.L.
(2)
+
-
Kapiteijn, E.H.W.
(2)
+
-
Meza, M.M. de
(2)
+
-
Speetjens, F.M.
(2)
+
-
Stevense-den Boer, M.
(2)
+
-
Tong, T.M.L.
(2)
+
-
Wreede, L.C. de
(2)
+
-
Show more
Language
en
(14)
+
-
Search results
(1 - 14 of 14)
show grid
show list
save search
Time trends in the treatment and survival of 5036 Uveal melanoma patients in The Netherlands over a 30-year period
CMTM6 shapes antitumor T cell response through modulating protein expression of CD58 and PD-L1
Seasonal variation of anti-PD-1 outcome in melanoma-Results from a Dutch patient cohort
Real-world outcomes of ipilimumab plus nivolumab combination therapy in a nationwide cohort of advanced melanoma patients in the Netherlands
A survival tree of advanced melanoma patients with brain metastases treated with immune checkpoint inhibitors
Health-state utilities in long-term advanced melanoma survivors comparable with the general population
Response to checkpoint inhibition and targeted therapy in melanoma patients with concurrent haematological malignancies
IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma
Adjuvant treatment of in-transit melanoma
Time interval from primary melanoma to first distant recurrence in relation to patient outcomes in advanced melanoma
Trends in incidence and survival of 1496 patients with mucosal melanoma in the Netherlands (1990-2019)
Population mortality in advanced melanoma patients with and without response and progression
Combining melphalan percutaneous hepatic perfusion with ipilimumab plus nivolumab in advanced uveal melanoma
Adjuvant BRAF-MEK inhibitors versus Anti PD-1 Therapy in stage III melanoma